2020
DOI: 10.1016/j.gtc.2020.04.006
|View full text |Cite
|
Sign up to set email alerts
|

Enhancing Scintigraphy for Evaluation of Gastric, Small Bowel, and Colonic Motility

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 86 publications
0
4
0
Order By: Relevance
“…Gastric emptying scintigraphy (GES) is the gold-standard test to determine stomach emptying, and it utilizes a radiolabeled low-fat meal (egg-white meal [EWM]) that has been unchanged for many years. 1 The two most common clinical indications of GES are gastroparesis and functional dyspepsia. 2,3 Both are distinct upper gastrointestinal (GI) sensorimotor disorders associated with meals and have significantly overlapping features.…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…Gastric emptying scintigraphy (GES) is the gold-standard test to determine stomach emptying, and it utilizes a radiolabeled low-fat meal (egg-white meal [EWM]) that has been unchanged for many years. 1 The two most common clinical indications of GES are gastroparesis and functional dyspepsia. 2,3 Both are distinct upper gastrointestinal (GI) sensorimotor disorders associated with meals and have significantly overlapping features.…”
Section: Introductionmentioning
confidence: 99%
“…It allows the assessment of different gastric functions in a single scan instead of conducting separate investigations with other modalities. 1,8,12 While the technique's early descriptions go back decades, 13 its practical realization is still lacking, and normative IMD 0h values remain scarce. 8 In light of new evidence on the associations between IMD patterns and symptom profiles, it is therefore relevant to explore and determine the normal IMD 0h .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…It also has the potential to help guide the assessment of response to therapy and to identify those patients with multiregional dysmotility, who are not easily distinguished clinically 1,2 . Currently, regional transit may be assessed using conventional methods, such as scintigraphy and radio‐opaque marker studies, 3–5 both of which are limited by lack of standardisation and radiation exposure. The wireless motility capsule (WMC) was approved by the Food and Drug Administration in 2006 and has been validated against these reference standard tests for use in gastroparesis and chronic idiopathic constipation 6,7 .…”
Section: Introductionmentioning
confidence: 99%